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Abstract: Background: Hepatitis B and C are major public health problems worldwide. It is generally believed that 
hepatitis B (HBV) and C (HCV) viruses are highly prevalent in the Republic of Yemen.  
Aim: to determine the prevalence of hepatitis B and C viral infection among patients attending the endoscopic clinic at Al-
Thowrah hospital in Sana'a City, Yemen.  
Methods: The descriptive cross-sectional study was carried out among patients attending to the endoscopic clinic at Al-
Thowrah hospital in Sana'a city from January to December 2017. 1592 patients attending the endoscopic clinic at Al-
Thowrah hospital were selected. The data were collected through a structured questionnaire were administered as a 
face to face interview. The questionnaire was included the following data: demographic data (age, sex, and marital 
status), and laboratory tests (HBsAg and HCV antibodies).  
Results: Overall 95.1% of the patients had never been exposed to HBV or HCV infections while 3.4% had HBsAg and 
1.5% had HCV infection. The prevalence of HBV and HCV infection among patients according to sex showed that in 
male 46.2% of the patients had HBsAg and 12.8% had HCV antibodies compared to 23.1% of the patients had HBsAg 
and 17.9% had HCV infection in females.  
Conclusions: It is essential to promote awareness of these risks among everyone.  
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INTRODUCTION 
Hepatitis B virus (HBV) and hepatitis C virus (HCV) 
are the major causes of liver diseases worldwide [1]. 
The World Health Organization (WHO) estimates that 
up to two billion people in the world have been infected 
with HBV; about 350 million people live with chronic 
HBV infection, and about 600,000 people die from 
HBV- related liver disease and 3–4 million persons are 
newly infected each year [2,3]. The prevalence of HBV 
in the Mediterranean countries is intermediate to be, 3-
5% [4,5]. The prevalence of chronic HBV infection 
varies geographically, from high (> 8 %), intermediate 
(2-7 %) to low (< 2 %) prevalence [6]. In Yemen, both 
HBV and HCV infections are present in the population. 
The endemicity of infection is considered high in 
Yemen, where the prevalence of positive HBsAg 
ranges from 8 % to 20 %, and up to 50 % of the 
populations generally have serological evidence of 
previous HBV infection [7]. In other studies, the 
prevalence of HBsAg in Yemen is 12.7 % –18.5 % [8]. 
However, the prevalence of antibodies to HCV is 1.7 % 
in healthy volunteers [9]. Most of the epidemiological 
studies were done in different cities in Yemen, the 
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prevalence rates of HBsAg and HCV antibodies are 
10.5 % and 2.3 % in Sana’a, 4.75 % and 0.6 % in 
Aden, 5.6 % and 0.8 % in Hajah, 26.3 % and 5.1 % in 
Soqotra respectively [10]. The main transmission 
routes of HBV are parenteral and perinatal. Sexual, 
household and occupational transmissions are also 
important [11,12]. HBV and HCV infection sources 
such as a razor, scissors, beauty treatments, tattooing, 
piercing, pedicure, manicure/ chiropody and skin care 
may also be important risk factors in developed and 
undeveloped areas [13-18]. In particular, reuse or 
sharing of contaminated materials like razor blades can 
be considered important routes for the transmission of 
HBV and HCV infection. It has been reported that 
hepatitis B viruses can live for several days in dried 
blood on table surfaces, needles, syringes, scissor and 
razors [19]. General reduction of these exposures and 
assuring sterile practices and safety precautions are 
logical goals for intervention [19].  
Aim of the Study 
To determine the prevalence of hepatitis B and C 
viral infection among patients attending the endoscopic 
clinic at Al-Thowrah hospital in Sana'a City, Yemen. 
MATERIALS AND METHODS  
The study was conducted among patients attending 
to the endoscopic clinic at Al-Thowrah hospital in 
2     Global Journal of Gastroenterology & Hepatology, 2018, Vol. 6 Ghanem and Al-Rabeei 
Sana'a City, Yemen. The descriptive cross-sectional 
study was carried out from January to December 2017. 
The target population was all patients attending the 
endoscopic clinic at Al-Thowrah hospital Sana'a city, 
Yemen. 16092 were admitted to this study. The data 
were collected through a structured questionnaire were 
administered as a face to face interview. The 
questionnaire was included the following data: 
demographic data (age, sex, and marital status), and 
laboratory tests (HBsAg and HCV antibodies).  
Five ml of blood sample were drawn from each 
participant through venipuncture using a sterile syringe. 
Serum was separated, labeled within two hours of 
collection and stored upright at -20°C. HBV infection 
was measured using enzyme-linked immunoassay 
(ELISA) (Elecsys-Hitachi High-Technology Corporation, 
2010, Tokyo, Japan,). HBsAg that was positive test 
was analyzed for IgM-Anti-HBc. Antibodies to HCV 
were tested using a third-generation ELISA (Elecsys). 
Samples that were positive in the ELISA test were 
analyzed for HCV-RNA by reverse transcription and a 
nested polymerase chain reaction (PCR). Patients with 
a positive test for at least one serological marker for 
HBV and a positive HCV-RNA test for HCV infection 
were considered seropositive. Standard techniques 
were applied according to the manufacturer’s 
guidelines.  
The data entry, editing, and analyses were done 
using of SPSS. Descriptive statistics of demographic 
variables and other characteristics of the participants 
were computed. Means and SD were calculated for 
quantitative variables and proportions for categorical 
variables. Study participants were informed about the 
procedure and purpose of the study in simple, clear 
language and that they were free to refuse 
participation.  
The informed consent form was obtained from study 
participants. During the investigation, disposable 
syringes were used for with drawing a blood sample to 
ensure avoiding blood transmitted infection. The 
confidentiality of collected data and for the results of 
investigations was assured the patients were informed 
about their HBV/HCV test results. 
RESULTS 
A total of 1592 patients were admitted to the study. 
The age ranges of patients were from 15 to 60 year, 
with mean age 28.2±8.3 years and 55.2% male and 
44.8% female. Nearly two-third 70.3% was married.  
Serological Tests 
The serological tests were completed for 1592 
patients. Overall 95.1% of the patients (1514/1592) had 
never been exposed to HBV or HCV infections while 
4.9% (78/1592) of patients were HBsAg and HCV 
antibodies positive cases (3.4% HBsAg vs 1.5% HCV 
antibodies) Figure 1.  
The prevalence of HBV and HCV infection markers 
among patients according to sex showed that in male 
46.2% of the patients had HBsAg and 12.8% had HCV 
antibodies compared to 23.1% of the patients had 
HBsAg and 17.9% had HCV infection in the female 
Table 1. 
 
Figure 1: Prevalence of HBV and HCV infection markers 
among patients (N=1592). 
 
Table 1: Prevalence of HBV and HCV Infection Markers 
among Patients According to Sex (N=78)  
Male Female Total 
Positive cases 
F % F % F % 
HBsAg 36 46.2 18 23.1 54 69.2 
HCV anti-bodies 10 12.8 14 17.9 24 30.7 
Total 46 58.9 32 41.0 78 100 
 
DISCUSSION 
The main sources of spread of hepatitis B and C are 
the non-implementation of international standards 
regarding blood transfusion, reuse of needles for ear 
and nose piercing, reuse of needles for injections, 
injecting drug users, shaving from barbers, tattooing, 
and use of unsterilized dental and surgical instruments. 
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Recently the rates of HBV infection in the country have 
been increasing, attributed to a lack of proper health 
facilities, low socioeconomic status and low public 
health awareness about the transmission of 
communicable diseases [20].  
A significant proportion of those exposed to HBV 
become chronically infected and are at considerable 
risk of liver cancer, chronic active hepatitis, and 
cirrhosis. These infected people may not be aware of 
their HBV status and are not clinically ill but are a 
source of infection to others. Messages about hepatitis 
need to be incorporated in media campaigns, in 
addition to regulation of practices. In addition, routine 
screening and immunization are mandatory in the high-
risk groups [21]. 
This survey was conducted to determine the 
prevalence of HBV and HCV infections and practices 
among patients. The prevalence of HBV and HCV 
infections among general population varies from 
country to country based on environmental factors and 
host characteristics [22].  Therefore, this study may fill 
a gap regarding thus information in Yemen.  
Prevalence of HBV and HCV may be different in 
different regions and various groups of the same 
community. In the present study, the prevalence of 
HBsAg was detected in 3.4%. This rate  is similar than 
reported among the general population in Aden 4.7 % 
but lower than that reported in Sana’a 10.5%, in Hajah 
5.6% and in Soqotra 26.3 % and higher than in Mukala 
2.7 % and in Ibb 1.81 % [23-25]. The prevalence of 
HBsAg was 7.4% [26] in the general population and 
(9.9%) [27] in healthcare workers in Yemen.  
In our study, the prevalence of  HCV  was detected 
in 1.5%, however, the prevalence of  HCV was only 
1.7% [26] and 3.5% [27] in general population and 
health workers in Yemen. In similar studies conducted 
among the general population in the different 
geographic region in Yemen found that HCV was 2.37 
% in Sana’a, 0.6% in Aden, 0.8 % in Hajah, 5.1 % in 
Soqotra and 1.99 % in Ibb city [23-25]. According to 
WHO, Yemen has an intermediate level, which is 2 % -
7 % of HBV and 2.5 % - 4.9 % of HCV  
The percentages of HBV and HCV infections among 
males were higher than in females (58.9% vs 41%), 
this may be the cause of males number in taken 
samples was higher. These people had a variable 
history of exposure to HBV and HCV risk factors such 
as major/dental surgery or blood transfusion. This 
increase could indicate an accumulated risk of infection 
over time. In addition, the results indicated that the 
horizontal spread of hepatitis B virus may be of a 
greater importance than vertical transmission. 
Inadequate information on the prevalence and risk 
determinants of viral hepatitis among the different 
population groups in Yemen are responsible for 
morbidity and mortality of HBV and HCV. 
CONCLUSION 
Infection with HBV and HCV is intermediate level 
among patients attending to the endoscopic clinic at Al-
Thowrah hospital in Sana'a City, Yemen.  
RECOMMENDATION 
Educate the community about the health risks of 
HBV and HCV and strategies for minimizing the risk of 
transmission can help reduce transmission of HBV and 
HCV. Nevertheless, further studies are needed to 
investigate their prevalence of HBV and HCV among 
the community. 
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